Insider Brief Quantum annealing–based drug design, demonstrated by PolarisQB’s QuADD platform running on a D-Wave Advantage system, can generate and optimize drug-like molecular candidates in minutes to hours rather than weeks or months, significantly reducing […]

Recent Comments